文献速递生殖医学

2013年欧洲辅助生殖技术:ESHRE欧洲登记处生成的结果

Assisted reproductive technology in Europe, 2013: results generated from European registers by ESHRE.
PubMed 文献 · Hum Reprod · 2017-01-01

该研究回顾性收集2013年欧洲38个国家1169家诊所的686271个辅助生殖技术周期及22个国家1095个宫腔内人工授精实验室的175467个夫精宫腔内人工授精和43785个供精宫腔内人工授精周期。结果显示辅助生殖技术总体周期数增加,妊娠率与2012年相比保持稳定,多胎分娩率未变,宫腔内人工授精活动与成功率与往年相似。

要点

  • 2013年欧洲辅助生殖技术周期数增加,妊娠率与2012年相比保持稳定。
  • 体外受精与卵胞浆内单精子注射中移植3个及以上胚胎的比例降低,但多胎分娩率未变。
  • 宫腔内人工授精活动与成功率与往年相似。

核心结论

  • 2013年欧洲辅助生殖技术总体周期数因报告国家增多而增加,妊娠率与2012年相比保持稳定,移植3个及以上胚胎的比例低于以往但多胎分娩率未变,宫腔内人工授精活动与成功率与往年相似。

研究设计与样本

  • 由欧洲人类生殖与胚胎学会欧洲体外受精监测联盟进行的回顾性数据收集,收集2013年1月1日至12月31日期间38个国家1169家诊所报告的686271个治疗周期,以及22个国家1095个宫腔内人工授精实验室报告的175467个夫精宫腔内人工授精和43785个供精宫腔内人工授精周期。

主要发现

  • 在17个所有诊所均向辅助生殖技术登记处报告的国家中,约3.1亿人口共进行374177个辅助生殖技术周期,相当于每百万人口1175个周期(范围235-2703个周期每百万人口)。
  • 所有体外受精周期的临床妊娠率每穿刺和每移植分别为29.6%(2012年为29.4%)和34.5%(2012年为33.8%),保持稳定。
  • 卵胞浆内单精子注射的相应妊娠率每穿刺和每移植分别为27.8%(2012年为27.8%)和32.9%(2012年为32.3%),也保持稳定。
  • 冻融胚胎替代周期的妊娠率每解冻/复温增至27.0%(2012年为23.1%),供卵周期新鲜移植妊娠率增至49.8%(2012年为48.4%)、解冻移植妊娠率增至38.5%(2012年为35.9%)、冻卵移植后妊娠率为46.4%(2012年为45.1%)。
  • 夫精宫腔内人工授精后的分娩率稳定在8.6%(2012年为8.5%),供精宫腔内人工授精后略低为11.1%(2012年为12.0%)。

关键数值与推荐

  • 体外受精和卵胞浆内单精子注射周期中移植1、2、3和4个及以上胚胎的比例分别为31.4%、56.3%、11.5%和1.0%(2012年相应为30.2%、55.4%、13.3%和1.1%)。
  • 体外受精和卵胞浆内单精子注射合计后的单胎、双胎和三胎分娩比例分别为82.%、17.5%和0.5%,总多胎分娩率为18.0%,2012年为17.9%。
  • 冻融胚胎替代周期的多胎分娩率为12.8%(双胎12.5%,三胎0.3%),2012年分别为12.5%、12.2%和0.3%。
  • 宫腔内人工授精周期中,夫精和供精后的双胎/三胎分娩率分别为9.5%/0.6%和7.5%/0.3%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 各国报告方法存在差异,一些国家的登记处无法提供部分相关数据,如启动周期和分娩。
  • 只要数据不完整且通过不同收集方法生成,结果应谨慎解读。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Are there any changes in the treatments involving ART and IUI initiated in Europe during 2013 compared with previous years? SUMMARY ANSWER: An increase in the overall number of ART cycles resulting from a higher number of countries reporting data was evident, the pregnancy rates (PRs) in 2013 remained stable compared with those reported in 2012, the number of transfers with multiple embryos (3+) was lower than ever before yet the multiple delivery rates (DRs) remained unchanged, and IUI activity and success rates were similar to those of last years. WHAT IS KNOWN ALREADY: Since 1997, ART data in Europe have been collected and reported in 16 manuscripts, published in Human Reproduction. STUDY DESIGN, SIZE, DURATION: Retrospective data collection of European ART data by the European IVF-monitoring Consortium for ESHRE. Data for cycles between 1 January and 31 December 2013 were collected from National Registers, when existing, or on a voluntary basis by personal information. PARTICIPANTS/MATERIALS, SETTINGS, METHODS: From 38 countries (+4 compared with 2012), 1169 clinics reported 686 271 treatment cycles including 144 299 of IVF, 330 367 of ICSI, 154 712 of frozen embryo replacement (FER), 40 244 of egg donation (ED), 247 of IVM, 9791 of PGD/PGS and 6611 of frozen oocyte replacements. European data on intrauterine insemination using husband/partner's semen (IUI-H) and donor semen (IUI-D) were reported from 1095 IUI labs in 22 countries. A total of 175 467 IUI-H and 43 785 IUI-D cycles were included. MAIN RESULTS AND THE ROLE OF CHANCE: In 17 countries where all clinics reported to their ART register, a total of 374 177 ART cycles were performed in a population of around 310 million inhabitants, corresponding to 1175 cycles per million inhabitants (range, 235-2703 cycles per million inhabitants). For all IVF cycles, the clinical PRs per aspiration and per transfer were stable with 29.6% (29.4% in 2012) and 34.5% (33.8% in 2012), respectively. For ICSI, the corresponding rates also were stable with 27.8% (27.8% in 2012) and 32.9% (32.3% in 2012). In FER-cycles, the PR per thawing/warming increased to 27.0% (23.1% in 2012). In ED cycles, the PR per fresh transfer increased to 49.8% (48.4% in 2012), to 38.5% (35.9% in 2012) per thawed transfer, and to 46.4% for transfers after FOR (45.1% in 2012). The DRs after IUI remained stable at 8.6% (8.5% in 2012) after IUI-H and was slightly lower after IUI-D (11.1% versus 12.0% in 2012). In IVF and ICSI cycles, 1, 2, 3 and 4+ embryos were transferred in 31.4, 56.3, 11.5, and 1.0% of the cycles, respectively (corresponding numbers were 30.2, 55.4, 13.3 and 1.1% in 2012). The proportions of singleton, twin and triplet deliveries after IVF and ICSI (added together) were 82., 17.5 and 0.5%, respectively, resulting in a total multiple DR of 18.0% compared to 17.9% in 2012. In FER-cycles, the multiple DR was 12.8% (12.5% twins and 0.3% triplets), nearly the same as in 2012 (12.5, 12.2 and 0.3% respectively). Twin and triplet DRs associated with IUI cycles were 9.5%/0.6% and 7.5%/0.3%, following treatment with husband/donor semen, respectively. LIMITATIONS, REASONS FOR CAUTION: The method of reporting varies among countries, and registers from a number of countries have been unable to provide some of the relevant data such as initiated cycles and deliveries. As long as data are incomplete and generated through different methods of collection, the results should be interpreted with caution. WIDER IMPLICATIONS OF THE FINDINGS: The 17th ESHRE report on ART shows a continuing expansion of the number of treatment cycles in Europe, with more than 685 000 cycles reported in 2013 and an increasing contribution to birth rate in many countries. However, the need to improve and standardize the national registries, and to establish validation methodologies, remains manifest. STUDY FUNDING/COMPETING INTEREST(S): The study has no external funding; all costs are covered by ESHRE. There are no competing interests.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Calhaz-Jorge C, De Geyter C, Kupka MS, et al. Assisted reproductive technology in Europe, 2013: results generated from European registers by ESHRE. Hum Reprod. 2017. PMID: 29117383. doi:10.1093/humrep/dex264

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。